Matthew+Naramore

**For Presentation:**  **Size and Organizational Design** **Technology and Organizational Design** **Environment and Organizational Design**
 * Novo Nordisk practices a bureaucratic control system that helps work with the growing size of the firm. Domestically located in Denmark, the firm has grown extensively and spread to larger countries like the US, and across several European countries. The challenges of size have been overcome with the use of implementing instantaneous communication tactics, such as video conferences, e-mail, and other technological methods of communication.
 * Their structure is considered as a "functional" structure, which simply put means each person is in charge of their own particular role, like security officer or research scientist. The firm has a small chain of command, consisting of eleven total members of the board of directors. Four of these eleven are elected by employees within the firm.
 * Despite the size of their firm, Novo Nordisk remains as one of the top pharmaceutical firms in the global economy (in regards of diabetic products). The internal structure of the firm is flexible and allows employees across borders to communicate efficiently and collaborate to ensure that business is not hindered because of the population and distance between each branch.
 * The modern technologies are obviously influential in the pharmaceutical industry, but the way that Novo Nordisk implements and utilizes these technologies is what makes them so great.
 * Novo Nordisk remains as one of the top pharmaceutical firms in maintaining practices that utilize the newest technology available. In research and development, equipment used in these operations is consistently updated and replaced with newer and more efficient tools.
 * Standards and procedures are adversely affected, and as a result Novo Nordisk not only sets the standards to maintaining ethical and effective research practices, but is consequently the 47th best firm to work for, as of 2011 ([|CNNMoney, 2011]). One of the causes of this are the benefits that researches and employees receive, not limited to just perks but inclusive of the technology that employees have access to and are provided.
 * Utilization of Gene Technology in research and development is a product of **information technology**, since this field is producing new information to be translated into knowledge which will further benefit the firm's capabilities and knowledge.
 * There are several external factors that affect the firm, particularly because of the state of the pharmaceutical industry as a whole. Over the past few years, the growth of pharmaceuticals has declined, however Novo Nordisk maintains strong cash inflow and low debts. This is achieved through the utilization of external factors, such as market trends and new laws and regulations. Novo Nordisk remains proactive in reducing their impact on the environment, which is today a large factor in building a sustainable image to customers. In 2006, Novo Nordisk signed an agreement with the World Wide Fund for Nature to reduce the firm's carbon emissions by 10% by the year 2014. This is extremely beneficial to the firm's image, and helps maintain successful business relations between the firm and its consumers.
 * On the flip side, threats exist and Novo Nordisk is aware of these potential issues. One of the major threats is the increase in prices of fuel. To address the issue, Novo Nordisk has improved the efficiency of their shipping tactics and increased the sizes of their orders. Additionally, they are implementing better distribution channels across countries that have infrastructures that permit these improvements. Fewer shipments with larger loads, as well as improving fuel efficiency, is helping to reduce the expenditures that are externally imposed on the firm, and help to alleviate this growing concern.
 * Environment complexity is the magnitude of problems and opportunities in the firm's environment, proven through the level of richness, interdependence and uncertainty. The pharmaceutical industry is very complex, because this is the exploration of how humans function, and much uncertainty exists in regards to finding appropriate cures and effective treatments for particular diseases.

**Firm:** <span style="font-family: Verdana,Geneva,sans-serif;">Novo Nordisk A/S

<span style="font-family: Verdana,Geneva,sans-serif;">**Chapter:** <span style="font-family: Verdana,Geneva,sans-serif;">Strategic Capabilities and Organizational Design

<span style="font-family: Verdana,Geneva,sans-serif;">**Concepts to Discuss:** <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> <span style="font-family: Verdana,Geneva,sans-serif;">**<span style="font-size: 14px; line-height: normal; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">1. What is your topic? ** <span style="font-family: Verdana,Geneva,sans-serif; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> **2. What company are you assessing as consultants?** <span style="font-family: Verdana,Geneva,sans-serif; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> **3. Provide some background information about the business** <span style="font-family: Verdana,Geneva,sans-serif;">**<span style="font-size: 14px; line-height: normal; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;">4. What topics/theories will you cover to explain the interesting/challenging/successful phenomenon going on in the company? ** <span style="font-family: Verdana,Geneva,sans-serif; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px;"> **5. Who will be responsible for discussing what theories?**
 * 1) <span style="font-family: Verdana,Geneva,sans-serif;">Strategy, Innovation, and Organizational Learning
 * 2) <span style="font-family: Verdana,Geneva,sans-serif;">Organizational Design
 * 3) <span style="font-family: Verdana,Geneva,sans-serif;">Designing for Greater Capability
 * 4) <span style="font-family: Verdana,Geneva,sans-serif;">Putting it all Together
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: 21px;">** Strategic Capabilities and Organizational Design (Chapter 18) **
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">Strategy, Innovation, and Organizational Learning
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">Organizational Design
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">Designing for Greater Capability
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">Putting It All Together
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">Novo Nordisk A/S
 * <span style="font-family: Verdana,Geneva,sans-serif;"> Novo Nordisk A/S is a pharmaceutical firm that is headquartered in Denmark. This firm is known for its high-quality diabetic products, research, and developments
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">The structure of the firm
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">The sustainability of the firm
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">The environmental contributions of the firm
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">An overview of the home country, and how its culture affects the firm
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: normal;">More to come...
 * <span style="font-family: Verdana,Geneva,sans-serif; font-size: 14px; line-height: 21px;">// Matthew: [Designing for Greater Capability] //